SubHero Banner
Text

Ofirmev® (acetaminophen) – Updated indications

January 27, 2017 – The FDA approved Ofirmev (acetaminophen) injection for the management of mild to moderate pain in adult and pediatric patients 2 years and older, management of moderate to severe pain with adjunctive opioid analgesics in adult and pediatric patients 2 years and older, and for the reduction of fever in adult and pediatric patients.

Download PDF